echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > The Synthetic Routes of methyl (33R,35S,91R,92R,5S,Z)-5-(tert-butyl)-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphan-12-yne-35-carboxylate

    The Synthetic Routes of methyl (33R,35S,91R,92R,5S,Z)-5-(tert-butyl)-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphan-12-yne-35-carboxylate

    • Last Update: 2023-05-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The Synthetic Routes of methyl (33R,35S,91R,92R,5S,Z)-5-(tert-butyl)-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphan-12-yne-35-carboxylate


    The pursuit of new drugs and the development of the pharmaceutical industry have led to a growing need for new and innovative synthetic methods.
    In this regard, the Synthetic routes of methyl (33R,35S,91R,92R,5S,Z)-5-(tert-butyl)-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphan-12-yne-35-carboxylate, a novel compound with potential pharmaceutical applications, have been the subject of extensive research.


    This compound is a unique synthesis of several structural units, making its synthesis challenging and complex.
    As a result, various synthetic routes have been developed to address this challenge.
    In this article, we will discuss the different synthetic methods that have been employed in the synthesis of methyl (33R,35S,91R,92R,5S,Z)-5-(tert-butyl)-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphan-12-yne-35-carboxylate.


    1. Heterocyclic Synthesis

    Heterocyclic synthesis is a widely used method for the synthesis of this compound.
    It involves the construction of the 1,2-cyclopropanacyclotetradecaphan heterocycle, which is a key structural unit of the compound, using various heterocyclic synthesis methods.
    The use of readily available building blocks, such as 1,3-oxazolidin-2-ones and 1,3-oxazolidin-4-ones, has been proposed as a convenient method for the synthesis of the 1,2-cyclopropanacyclotetradecaphan ring.


    1. Pd/C-catalyzed redox homologation

    Pd/C-catalyzed redox homologation is another synthetic method that has been employed in the synthesis of methyl (33R,35S,91R,92R,5S,Z)-5-(tert-butyl)-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphan-12-yne-35-carboxylate.
    This method involves the use of Pd/C as a catalyst to promote the redox reaction between the building blocks, leading to the formation of the target compound.


    1. Direct reaction of an iodoalkene with (S)-2-iodomalonate

    Direct reaction of an iodoalkene with (S)-2-iodomalonate is another method that has been employed in the synthesis



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.